BOT 1.59% 32.0¢ botanix pharmaceuticals ltd

Just a Wednesday reminder of whose steering this ship...'Mr...

  1. 502 Posts.
    lightbulb Created with Sketch. 113
    Just a Wednesday reminder of whose steering this ship...

    'Mr Callahan is an experienced life sciences executive based in Philadelphia. He is the founding CEO of iCeutica Inc and Churchill Pharma Inc. and a co-inventor of some of the technologies that comprise the SoluMatrix Fine Particle Technology™ drug delivery platform that iCeutica uses to develop new pharmaceuticals. iCeutica has developed 3 products to date that have received FDA approval. He has more than 20 years legal, IP and investment management experience and is also a director of Glycan Bioscience LLC.Mr Callahan has worked as an investment director for two venture capital firms investing in life sciences, clean technology and other sectors and was General Manager and General Counsel with Australian listed technology and licensing company ipernica (now Nearmap ASX:NEA), where he was responsible or the licensing programs that generated more that $120M in revenue.'

    An experienced pharma executive, IP Lawyer, has involvement with multiple FDA product approvals, a ton of listed company and capital raising experience and most importantly previous experience with selling a business to big pharma! I'm of the opinion, he is one of the best people getting around in this sector to manage an upcoming biopharma company.  
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
32.0¢
Change
0.005(1.59%)
Mkt cap ! $707.4M
Open High Low Value Volume
31.5¢ 32.5¢ 31.0¢ $1.169M 3.655M

Buyers (Bids)

No. Vol. Price($)
9 274982 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 48600 2
View Market Depth
Last trade - 16.10pm 22/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.